A

Alexander M. Lesokhin

Memorial Sloan Kettering Cancer Center

ORCID: 0000-0001-9321-702X

Publishes on Multiple Myeloma Research and Treatments, CAR-T cell therapy research, Protein Degradation and Inhibitors. 564 papers and 24.9k citations.

PubIndex Score93Top 7% · seniorHow it's scored

564Publications

24.9kTotal Citations

First publication: 1999First senior author: 2010

Multiple Myeloma Research and Treatments CAR-T cell therapy research Protein Degradation and Inhibitors Cancer Immunotherapy and Biomarkers Immunotherapy and Immune Responses

Top publicationsby citations

Nivolumab plus Ipilimumab in Advanced Melanoma

Jedd D. Wolchok, Mario Sznol, Harriet M. Kluger et al.|New England Journal of Medicine|2013

Cited by 4.2k

Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma

Michael A. Postow, Jedd D. Wolchok, Margaret K. Callahan et al.|New England Journal of Medicine|2012

Cited by 2.1k

Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results

Alexander M. Lesokhin, Mohamad Mohty|Nature Medicine|2023

Cited by 534

GPRC5D-Targeted CAR T Cells for Myeloma

Sham Mailankody, Eric L. Smith, Sean M. Devlin et al.|New England Journal of Medicine|2022

Cited by 383

Cevostamab Monotherapy Continues to Show Clinically Meaningful Activity and Manageable Safety in Patients with Heavily Pre-Treated Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results from an Ongoing Phase I Study

Suzanne Trudel, Simon J. Harrison, Rafaël Fonseca et al.|Blood|2021

Cited by 161